OBJECTIVES: This study aimed to develop a prediction model for less invasive lesions of pathological Stage IA adenocarcinomas.
INTRODUCTION
Because of the increase in lung cancer screening with computed tomography (CT), more lesions such as early-stage lung adenocarcinomas are detected [1, 2] . Early-stage lung adenocarcinoma is represented by a faint opacity on high-resolution computed tomography (HRCT) images. The opacity is called 'ground-glass opacity' (GGO) [3] . Patients with GGO-dominant small lesions have an excellent prognosis after complete resection [4] . The consolidation-to-tumour ratio (CTR) is widely utilized as the 2D radiological parameter, and lesions with a CTR <0.5 are candidates for sub-lobar resection instead of lobectomy [5] . However, a discordance can exist between radiological features and the pathological invasiveness of an adenocarcinoma. Some lesions diagnosed as a pure GGO may actually be invasive adenocarcinomas [6] . The 2D parameters obtained from HRCT images may provide insufficient criteria to predict the pathological invasiveness of a lesion.
Fluorodeoxyglucose positron emission tomography (FDG-PET) and HRCT are used for lung cancer staging before an operation. Many studies show that a lesion with a high maximum standardized uptake value (SUVmax) is associated with advanced stage disease and a poor prognosis [7] . However, only a few reports have shown that FDG-PET is a promising modality to predict preoperatively the histological invasiveness of early-stage lung adenocarcinomas [8] . There are no evident criteria to discern less invasive lesions in the broad spectrum of adenocarcinoma pathologies.
Technological advances in the field of image analysis software such as 3D CT volumetry have provided novel 3D parameters of lesions on HRCT images [9] . Some 3D parameters are whole tumour volume, solid-part volume and the ratio of the solid-part volume to whole tumour volume [10, 11] . In Europe, a lung cancer screening trial, the Dutch-Belgian Randomized Lung Cancer Screening [NEderlands Leuvens Longkanker Screenings Onderzoek (NELSON)] trial, was conducted by assessing the volumetric change as the nodule management protocol [12] . However, there has been little research on the efficacy of 3D evaluation with regard to the 3D parameters and the pathological invasiveness of adenocarcinoma [13] . Moreover, no study has addressed the prediction of less invasive lesions using HRCT and FDG-PET together to compensate for the incompleteness of applying either of these 2 modalities alone. Therefore, the purpose of this study was to predict less invasive lesions in patients with pathological Stage IA adenocarcinoma using parameters obtained from HRCT images and FDG-PET images through 3D CT volumetry.
MATERIALS AND METHODS

Patients
We retrospectively evaluated 128 patients who underwent curative resection for pathological Stage IA adenocarcinoma from February 2014 to October 2016 at St. Luke's International Hospital (Tokyo, Japan). Fourteen patients were excluded for the following reasons: (i) HRCT images were unavailable (4 patients), (ii) FDG-PET images were unavailable (8 patients) and (iii) HRCT images showed inflammatory changes around a lesion (2 patients). A total of 114 patients were included for analysis. This study was approved by the institutional review board of St. Luke's International Hospital (approval no. 16-R148). The requirement for informed consent from each patient was waived, because this study was a retrospective review of the database of the included patients.
Radiological examinations
All lesions were preoperatively scanned by HRCT using 3 CT scanners (Aquillion ONE: Toshiba Medical System, Tokyo, Japan; Revolution: GE Healthcare, Tokyo, Japan and Optima 660: GE Healthcare) with 120 kV, automatic mAs and bone reconstruction algorithm. All images were reconstructed within 1.0-1.25 mm thickness. However, FDG-PET/CT was also routinely preoperatively performed using the Discovery PET/CT 690 scanner (GE Healthcare). For PET/CT, patients fasted at least 6 h, and the serum glucose level was checked to ensure it was less than 200 mg/dl before examination. One hour before PET imaging, 150-300 MBq of FDG was injected intravenously.
Three-dimensional image analysis of the included lesions
Using the SYNAPSE VINCENT software programme (Fujifilm Medical, Tokyo, Japan), lesions on HRCT were extracted and separated semiautomatically into 2 parts, based on Hounsfield units (HU) (Fig. 1) : the GGO part was the area containing -800 HU to -300 HU and the solid part was the area containing -300 HU or more [14] . The ratio of the maximum diameter of consolidation to the maximum diameter of tumour (i.e. the CTR) and the ratio of the solid-part volume to the whole tumour volume (STR) were determined. The CTR and STR were measured semiautomatically by the software programme. The SUVmax was also measured using the programme. The cut-off values were set to 0.5 for CTR, 0.125 for STR and 1.0 for SUVmax. The ratio 0.125 was calculated by cubing the ratio of 0.5 from the volume ratio.
Pathological information
Pathological information was obtained from the pathology reports of the included patients. Histological subtypes of adenocarcinoma were determined, based on International Association for the Study of Lung Cancer (IASLC), American Thoracic Society (ATS) and European Respiratory Society (ERS) classifications such as adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma or invasive adenocarcinoma (e.g. lepidic, acinar, papillary, micropapillary, solid and invasive mucinous) [15] . We defined AIS and minimally invasive adenocarcinoma as less invasive lesions. All lesions were also evaluated, based on the seventh edition of the tumour node metastasis (TNM) classification [16] .
Statistical analysis
To characterize the lesions, descriptive analysis was used such as the maximum diameter of tumour described in the patients' pathological reports, solid tumour volume and whole tumour volume and all the aforementioned radiological parameters calculated through 3D volumetry (e.g. CTR, STR and SUVmax). Univariable logistic regression was used to estimate relevant differences between less invasive lesions and invasive lesions. To determine the predictors of less invasive lesions, multivariable logistic regression was subsequently performed. The parameters of lesions with a P-value of <0.05 were selected for the final predictors. Scores for each predictor were obtained from the beta value of the prediction model. A receiver operating characteristic curve was drawn, and the area under the curve was obtained. For the internal validation, the bootstrapping technique with 1000 iterations was used to simulate unbiased expected future performance [17, 18] . In our primary model, we considered the pathological invasiveness without considering the dependency structure between repeated measurements from the same patient. Thus, 7 of the 114 patients in the analysis possess multiple lesions. We chose this method as primary results, because we predict less invasive lesion using only radiological information, utilizing real-world setting clinical data. Subsequently, we run the sensitivity analyses, considering the influence of repeated measurements by excluding patients who have multiple lesions from all patients: all 107 patients had single radiological information. All analyses were conducted using SPSS software package, version 18.0 (SPSS, Chicago, IL, USA).
RESULTS
Among the 114 patients we analysed, 7 patients had 2 lesions. One hundred twenty-one lesions of pathological Stage IA were enrolled. The characteristics of the enrolled patients and lesions are presented in Tables 1 and 2 , respectively. Thirty-four (28.1%) lesions were diagnosed as AIS or minimally invasive adenocarcinoma and classified as the less invasive group. The remaining 87 (71.9%) lesions were classified as the invasive group. Table 3 presents the univariable and multivariable analyses results of the predictive factors of less invasive lesions. An STR <0.125 and an SUVmax <1.0-but not CTR <0.5-were selected as candidates for the prediction rules, and CRT <0.5 showed no significant difference. Table 4 presents the results of the multivariable analysis by the selected rules and the score points calculated by each beta value.
The receiver operating characteristic curve was drawn by calculating the sum of scores for each lesion (Fig. 2) . The area under the curve of this prediction rule was 0.858 (95% confidence interval 0.775-0.942). The prediction model had a total score of 3 points: SUVmax <1.0 was 1 point and STR <0.125 was 2 points. When the total score was 0 point, 1 point, 2 points or 3 points, the probability of a less invasive lesion was 7.4%, 12.5%, 42.3% and 89.5%, respectively (Fig. 3) .
A bootstrap cross-validation with 1000 iterations was conducted for the internal validation of the prediction model. A comparison between the original beta coefficient and the bootstrapped validation beta coefficient is shown in Table 5 . Scores of each predictor obtained from the bootstrapping technique are the same as that obtained from the original model. We confirmed that the model that incorporated 107 patients with a single lesion and excluded patients with multiple lesions was identical to the original model (see Supplementary Material, Table S1 , Fig. S1 ).
DISCUSSION
This study revealed that, for pathological Stage IA adenocarcinomas, the prediction model generated from FDG-PET and HRCT imaging could predict less invasive lesions at a high rate of approximately 90%. The evaluation in 3D was more accurate than that in 2D in the model using the image analysis software programme. The data are represented as the mean ± standard deviation, unless otherwise indicated. The maximum standardized uptake value is calculated by encircling the lesion as a spheroidal shape, using the same programme.
A relationship has been reported between parameters obtained from HRCT and the pathological invasiveness of adenocarcinoma [19] . In particular, a CTR <0.5 has been reported as a borderline value that distinguishes between a poor prognosis and a good prognosis in patients [20, 21] . For this reason, we applied 0.5 as the cut-off value and utilized the cube of the value as the volume ratio (i.e. the STR); a value below 0.125 was the rule to predict less invasive lesions.
In predicting less invasive lesions, the evaluation of the STR as the 3D parameter was more accurate than the evaluation of the CTR as the 2D parameter using 3D CT volumetry for early-stage lung adenocarcinomas, as shown in Table 3 . Some research has demonstrated the efficacy and reproducibility of 3D evaluation for lung nodules [9, 13] . Evaluation in 2D may fail to give an overview of a lesion, because a lesion usually grows asymmetrically in 2D and 3D. As expected, we were able to show the superiority of 3D parameters in predicting less invasive lesions.
With regard to the superiority of 3D evaluation, a possible clinical implication is that the use of the CTR will be replaced by the STR in the future. It is easy to measure tumour sizes (e.g. obtaining the CTR from HRCT images); however, interobserver differences in the size of manually measured tumours may occur, even among thoracic radiologists [22] . However, especially through 3D CT volumetry, quantitative parameters measured using areas strictly defined by the HU value could resolve interobserver differences. With the increasing prevalence of 3D CT volumetry, 2D and 3D parameters (e.g. tumour length and tumour volume) are easily obtained only from HRCT images.
Using FDG-PET with HRCT for the preoperative evaluation, clinicians can know the probability of less invasive lesions before surgery. In general, FDG-PET has been used preoperatively to evaluate the extent of disease [23] . The SUVmax of a lesion has been used to reflect the prognosis of patients, even in patients with early-stage lung cancer [24] . In clinical Stage IA lung adenocarcinoma, a previous study [25] showed that a criterion to discern AIS among part-solid nodules was an SUVmax <1.0. Other studies [5, 26] have shown that, along with the absence of nodal metastasis, a criterion to judge the indication for a sub-lobar resection was an SUVmax <1.5. In this study, the criterion was set at <1.0 to discern less invasive lesions among p-Stage IA lung adenocarcinomas. Differences among the criteria of SUVmax imply that potential candidates of sub-lobar resection exist, even among invasive adenocarcinomas having an SUVmax between 1.0 and 1.5.
Since the report of the Lung Cancer Study Group in 1997, lobectomy has been selected as the standard treatment procedure against primary lung cancer [27] . However, several studies [5, 28] have revealed that GGO-dominant lesions have a good prognosis, even when the lesions are removed by sub-lobar resection. Therefore, the criteria for sub-lobar resection of small lesions in the peripheral lung field have been investigated prospectively in Japan. In this study, a novel prediction model using 3D CT volumetry potentially distinguishes between less invasive lesions in patients with p-Stage IA lung adenocarcinomas. In the future, for full-score lesions in the model, wedge resection with sufficient margin may be an acceptable procedure from the viewpoint of less invasiveness in the histological evaluation. Therefore, this 
Limitations
This study has several limitations. First, this retrospective study was conducted at a single institution in Japan, where low-dose CT checking is very common; thus, there may have been a selection bias. Second, the number of included lesions was small due to the limited inclusion criteria of the study. Third, in actual clinical settings, small lesions in the peripheral lung fields contain different histological types, not just adenocarcinomas. The predictive model needs to be applied prospectively to these lesions to confirm the adequacy of this model. Fourth, from the viewpoint of interobserver differences, most measurements of the parameters were performed by the image analysis programme software. When a mistake occurred in drawing an outline of a lesion, which was uncommon, the outline was corrected by the observer and the parameters were then measured automatically.
CONCLUSION
In early-stage lung adenocarcinoma, a prediction model that was based on preoperative imaging modalities enabled us to predict less invasive lesions. Applying and refining the model could lead to the precise indications for sub-lobar resection with regard to the invasiveness of lesions. The combination of HRCT and FDG-PET in 3D CT volumetry enabled us to predict less invasive lesions in patients with early-stage lung adenocarcinoma. The prediction model needs external validation in the future. Figure 3 : The probability of less invasive lesions, based on the prediction scores: a maximum standardized uptake value <1.0 is 1 point and a solid tumour ratio <0.125 is 2 points each. CI: confidence interval; STR: solid tumour ratio; SUV max: maximum standardized uptake value. Figure 2 : The receiver operating characteristic curve of the prediction scores for less invasive lesions. AUC: area under the curve; CI: confidence interval.
